Next Generation Dx Summit convenes more than 1,000 international diagnostic professionals for valuable networking and comprehensive programming spanning from clinical diagnostics to business strategy. Now in its eighth year, the event has grown to include novel immunotherapy biomarkers, cell-free DNA, companion diagnostics, infectious disease, point-of-care, pharmacy-based diagnostics, commercialization, and reimbursement. New programming in 2016 includes prenatal diagnostics, circulating tumor cells, forensics, telemedicine and microbiome sequencing. The Next Generation Dx Summit is a must-attend event with complete coverage of the most timely and important issues for the industry.Programs include:
- Enabling Point-of-Care Diagnostics
- Circulating Tumor Cells
- Companion Diagnostics: Strategy & Partnerships
- Coverage and Reimbursement of Advanced Diagnostics
- DNA Forensics
- Clinical NGS Assays
- Hospital Laboratory Design and Renovation
- Molecular Diagnostics for Infectious Disease
- Clinical Application of Cell-Free DNA
- Diagnostics to Guide Cancer Immunotherapy
- Commercialization of Molecular Diagnostics
- Leveraging Pharmacies for Rapid Diagnostics
- NGS Diagnostics: Data Considerations, Annotation and Interpretation
- Advances in Microbiome Diagnostics
- Predictive Cancer Biomarkers
- Non-Invasive Prenatal Testing
- Health and Wellness Genomic Screening
- The Business of Telemedicine
- Digital PCR
More information: http://www.nextgenerationdx.com/